Article info
PDFCase Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Amelioration of trichotillomania with onabotulinumtoxinA for chronic migraine
- Correspondence to Dr Emily Rubenstein Engel; engel.emily{at}scrippshealth.org
Citation
Amelioration of trichotillomania with onabotulinumtoxinA for chronic migraine
Publication history
- Accepted January 26, 2023
- First published February 2, 2023.
Online issue publication
February 02, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.